supported-by

Subscribe to NPS Conference Updates

NAME:

E-MAIL:

This field should be left blank

Send

Please wait...

ORGANISED BY

SUPPORTED BY

threetwonineone-two

CONFERENCE COMMITTEE

Organising Committee:

Dr Ornella Corazza
University of Hertfordshire

Prof Giuseppe Bersani
Sapienza University of Rome

Dr Andres Roman-Urrestarazu
Maastricht University 

Scientific Committee:

Dr Ornella Corazza (Chair)
University of Hertfordshire

Dr Roumen Sedefov
European Monitoring Centre for Drugs and Drug Addiction

Dr Ana Gallegos
European Monitoring Centre for Drugs and Drug Addiction

Dr Olivier Rabin
World Anti-Doping Agency

Dr Justice Tettey
United Nations Office on Drugs and Crime

Martin Raithelhuber
United Nations Office on Drugs and Crime

Prof Fabrizio Schifano
University of Hertfordshire

Prof Giuseppe Bersani
Sapienza University of Rome

Prof Zsolt Demotrovics
Eötvös Loránd University

Prof Giovanni Martinotti
University of Chieti-Pescara

Prof Andy Parrott
Swansea University

threesixoneone-two

INVITED SPEAKERS

CONFERENCE PROGRAMME

VENUE LOCATION

space

ABOUT THE CONFERENCE

We are pleased to announce that the VI International Conference on Novel Psychoactive Substances (NPS) will be held on 8th – 9th April 2019 at the University of Maastricht in the Netherlands.

The series, which started in Budapest in 2012, aims to share knowledge and strengthen collaboration on NPS among multidisciplinary professionals at the international level.

The conference is jointly organised by the United Nations Office on Drugs and Crime (UNODC), the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the World Anti-Doping Agency (WADA), University of Hertfordshire, University of Maastricht and Sapienza University of Rome.

the-main-objectives-of-this-conference-are

THE MAIN OBJECTIVES OF THIS CONFERENCE ARE:

• Sharing evidence-based information on NPS and latest trends of misuse;

• Improving understanding of clinical treatment and management of NPS use;

• Exploring policy and legislative responses to NPS;

• Developing innovative prevention measures for vulnerable individuals;

• Identifying public health implications of NPS;

• Exploring motivations and socio-cultural factors underlying NPS use;

• Networking and providing the opportunity to meet leading experts in the field.

previous-editions

PREVIOUS EDITIONS

I International Conference on Novel Psychoactive Substances, Budapest, 2012.

Download Programme

II International Conference on Novel Psychoactive Substances, Swansea, 2013.

Download Programme

III International Conference on Novel Psychoactive Substances, Rome, 2014.

Download Programme

IV International Conference on Novel Psychoactive Substances, Budapest, 2016.

Download Programme

V International Conference on Novel Psychoactive Substances, Vienna, 2017.

Download Programme

conference-venue

CONFERENCE VENUE

The VI International Conference on Novel Psychoactive Substances (NPS) will be held on 8th – 9th April 2019 at the University of Maastricht in the Netherlands.

GET DIRECTIONS

registration-two

Registration

Early bird registrations will open on Monday 3rd September 2018 and close on Saturday 1st December 2018. After this date, a standard registration rate will apply until Friday 5th April 2019.

Abstract submission will open on Wednesday 1st August 2018 and close on Saturday 1st December 2018.

---

Standard delegate: 280 €

Early bird standard delegate: 220 €

Student delegate: 180 €

Early bird student delegate: 140 €

Register as presenter

ABSTRACT SUBMISSION

Authors (Initial(s) of the given name(s) and Surname e.g. J.W. White(*)

Affiliation of the first author

Professional role(*)

Email of first author(*)

Normally the presenting author

Abstract title(*)

Structured Abstract(*)

Introduction: Methods: Results: Conclusions:

Max 250 words.

Please indicate your preferred mode of delivery(*)

Oral

Poster

Please indicate your preferred session(*)

Public Health, Policy, Legislation Detection and Identification Epidemiology and Early Warning Systems Neuroscience and Cognition Fentanyl's NPS uses and trends NPS treatment and clinical management Doping and Enhancement Drugs

The space available for oral papers is quite limited. If you wish to present an oral paper please register early, and submit your abstract early.

First author photoYour photo will be used in the delegate social network

Browse...

Maximum size 5MB. Supported file types: jpg, jpeg, png, gif

First author bio(*)

Maximum 150 words

I confirm that I have read and agree with the following points.(*)

Yes I agree!

This field should be left blank

Submit now

Please wait...

Register as delegate (without abstract)

Your title(*)

MR MRS MS MISS PROF DR OTHERS

Your title if choose "Others"

First name(*)

Last name(*)

Country(*)

Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua And Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia And Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, The Democratic Republic Of The Cook Islands Costa Rica Cote D'Ivoire Croatia (Local Name: Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France, Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard And Mc Donald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic Of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic Of Korea, Republic Of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, Former Yugoslav Republic Of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States Of Moldova, Republic Of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts And Nevis Saint Lucia Saint Vincent And The Grenadines Samoa San Marino Sao Tome And Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia, South Sandwich Islands Spain Sri Lanka St. Helena St. Pierre And Miquelon Sudan Suriname Svalbard And Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic Of Thailand Togo Tokelau Tonga Trinidad And Tobago Tunisia Turkey Turkmenistan Turks And Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis And Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe

Organization - Official Name(*)

Organization - Abbreviation(*)

Email(*)

Motivation for attending(*)

Maximum 300 words

I confirm that I have read and agree with the following points.(*)

Yes I agree!

This field should be left blank

PAY NOW

Please wait...